Onderzoeker
Tine Van Bergen
- Disciplines:Oftalmologie en optometrie
Affiliaties
- Onderzoeksgroep Oogziekten (Afdeling)
Lid
Vanaf1 feb 2008 → 28 feb 2015
Projecten
1 - 1 of 1
- PIGF-inhibitie als nieuwe therapeutische benadering voor filtratiefalen na glaucoom filtratiechirurgie.Vanaf1 mrt 2013 → 28 feb 2015Financiering: IWT /VLAIO persoonsgebonden financ. - innovatiemandaten
Publicaties
1 - 10 van 30
- Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema(2018)
Auteurs: Tine Van Bergen
Pagina's: 2823 - 2836 - Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy(2017)
Auteurs: Tine Van Bergen, Tjing Hu, Lieve Moons
Pagina's: 136 - 150 - Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery(2016)
Auteurs: Tine Van Bergen, Evelien Vandewalle, Lieve Moons, Ingeborg Stalmans
Pagina's: 6428 - 6439 - The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery(2016)
Auteurs: Tine Van Bergen, Lieve Moons, Ingeborg Stalmans
Pagina's: 4347 - 4355 - Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery(2015)
Auteurs: Tine Van Bergen, Evelien Vandewalle, Lieve Moons, Ingeborg Stalmans
Pagina's: 667 - 678 - Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma(2015)
Auteurs: Davine Sijnave, Tine Van Bergen, Nele Kindt, Evelien Vandewalle, Lieve Moons, Ingeborg Stalmans
Pagina's: 1120 - 9 - Rho kinase inhibition, a versatile therapy for modulating wound healing in corneal pathologies(2015)
Auteurs: Ingeborg Stalmans, Lieve Moons, Tine Van Bergen
- Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery(2015)
Auteurs: Sarah Van de Velde, Tine Van Bergen, Evelien Vandewalle, Nele Kindt, Lieve Moons, Ingeborg Stalmans
Pagina's: 283 - 297 - Bevacizumab revisited: its use in different mouse models of ocular pathologies(2015)
Auteurs: Karolien Hollanders, Tine Van Bergen, Sarah Van de Velde, Davine Sijnave, Evelien Vandewalle, Lieve Moons, Ingeborg Stalmans
Pagina's: 611 - 621 - The Effect of AMA0428, a Novel and Potent ROCK Inhibitor, in a Model of Neovascular Age-Related Macular Degeneration(2015)
Auteurs: Karolien Hollanders, Tine Van Bergen, Nele Kindt, Evelien Vandewalle, Lieve Moons, Ingeborg Stalmans
Pagina's: 1335 - 1348
Patenten
1 - 1 van 1